Product Liability
Roundup (Glyphosate) Litigation: Where the Claims Stand
A factual overview of the glyphosate Roundup litigation: the federal MDL, jury verdicts, the 2026 Supreme Court preemption ruling, and Bayer's settlement.
Topic
Product Liability
How US product liability claims work: manufacturing and design defects, failure-to-warn allegations, recalls, and the consolidated proceedings over industrial and consumer products.
4 articles
Last updated
Product liability is the body of US law that lets an injured person pursue a seller or manufacturer for harm caused by a product. Three theories do most of the work, and the evidence needed for each is different:
- Design defect. The product line itself is alleged to be unreasonably dangerous as designed.
- Manufacturing defect. The individual unit departed from the intended design.
- Failure to warn. The product was adequately made, but the warnings or instructions were alleged to be inadequate, usually on the theory that a different warning would have changed the decision to use it.
A recall or a regulatory safety communication is evidence, not a verdict. It can support a failure-to-warn claim, and agencies’ own language about a hazard is often quoted in complaints, but a recall does not decide causation or damages.
Current articles
- Roundup and glyphosate litigation covers the trials, appeals and settlement programmes that followed the first jury verdicts.
- Paraquat and Parkinson’s disease claims covers the regulatory record for the herbicide and the consolidated federal claims.
- NEC infant formula litigation covers claims over specialised formula for premature infants, including the 2024 trial outcome and the federal consolidation.
Related sections: pharmaceutical lawsuits, medical device litigation and environmental litigation.
Product Liability
Paraquat and Parkinson's Claims: What the Record Shows
A factual overview of the paraquat Parkinson's litigation: EPA's 2021 interim decision, the federal MDL in Illinois, and what remains undecided.
Product Liability
NEC Infant Formula Litigation: Verdicts, MDL 3026 and Status
A fact-checked review of necrotizing enterocolitis litigation over preterm infant formula: MDL 3026, the verdicts, the 2026 rulings and what is still open.
Product Liability
Acetaminophen and Autism Claims: What MDL 3043 Shows
A factual review of the acetaminophen and autism litigation: MDL 3043 in New York, the court's rulings on expert testimony, and what remains undecided.